You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline

You are reading 1 of 2 free-access articles allowed for 30 days

The treatment of acne

By Mindo - 23rd Mar 2020 | 17 views

Acne skin because the disorders of sebaceous glands productions

Acne treatment should aim to eliminate the emotional stress associated with the condition and prevent physical scarring, Consultant Dermatologist at Tallaght University Hospital Prof Maureen Connolly told the Primary Care Society of Ireland (PCDSI) meeting in Cork at the end of February.

Prof Maureen Connolly

When assessing acne, she recommended that GPs examine the type of lesions, severity, psychological impact, scarring and post-inflammatory hyperpigmentation.

The European guidelines grade acne as follows: Comedonal acne; mild-to-moderate papulopustular acne; severe papulopustular/moderate nodular acne; and severe nodular/conglobate acne.

Prof Connolly advised GPs to counsel the patient on any side-effects from topical treatments, including, for instance, staining of bed clothes and towels, and skin irritation from benzoyl peroxide (BPO).

Retinoids, antibiotics and azelaic acid are also used topically for acne. Retinoids can cause skin irritation and burning sensations. A ‘pea-sized’ amount at night, two-to-three times a week for two weeks on patients is advised in management, with usage slowly increased, depending on how it is tolerated by the patient, Dr Connolly advised.

Azelaic acid is effective for post-inflammatory hyperpigmentation and is antimicrobial and anti-inflammatory. Side-effects include dryness, pruritus and rash.

Prof Connolly stressed the importance of avoiding oral and topical antibiotic use at the same time, as this can increase antibiotic drug resistance.

“Dermatologists are big prescribers of antibiotics so we have to watch our antibiotic prescriptions due to resistance,” Dr Connolly commented.

She added: “Do not use antibiotics on their own; use a fixed combination topical preparation, as this increases their efficacy.”

Recommended antibiotics include clindamycin/BPO, isotretinoin/erythromycin; and tretinoin/clindamycin.

Trimethoprim (200-300mg twice daily) is not licensed in acne but is useful for resistant acne. She cautioned, however, that 4 per cent of patients can develop a widespread, maculopapular rash with trimethoprim, as well as haematological relations. Furthermore, anti-androgen treatment can prove useful for women with acne that has characteristics suggesting a significant hormonal influence.

It is also useful when there has been an inadequate response to other treatments, and for acne that began or worsened in adulthood.

New acne treatments include sarecycline, tazarotene foam 0.1%, trifarotene cream, topical minocycline and clascoterone.

Sarecycline is a novel compound with a narrower spectrum of activity compared to other tetracyclines, Prof Connolly informed delegates. It is FDA-approved and the first antibiotic licensed for acne in four decades. In terms of diet and acne, Prof Connolly remarked that “evidence supports a role for high glycaemic index/glycaemic-load diets and dairy products (whole, low fat and skimmed milk) as exacerbating factors for acne; however patients should be advised that dietary factors do not independently cause acne”.

Patients should be encouraged to discontinue whey protein supplements, while yoghurt and cheese in the diet is “okay”, Prof Connolly noted.

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read